Table 1 Baseline clinical, demographic, histologic and metabolic characteristics of 77 patients with chronic hepatitis C
Patients (number) | 77 |
|---|---|
Age (years) | 56.1 ± 12.4 |
Sex [male/female] | 31/46 |
Body mass index (kg/m2) | 23.5 ± 2.9 |
 Male (kg/m2) | 23.8 ± 2.9 |
 Female (kg/m2) | 23.3 ± 3.1 |
HCV serotype [I/II] | 47/30 |
Viral load of HCV (log IU/ml) | 5.9 ± 1.1 |
Platelet count (×104/μl) | 18.1 ± 7.2 |
Total cholesterol (mg/dl) | 170.7 ± 38.6 |
Albumin (g/dl) | 4.3 ± 0.4 |
ALT (IU/l) | 64.5 ± 53.9 |
γ-GTP (IU/l) | 50.1 ± 62.2 |
Diabetes [absent/present] | 60/17 |
Hemoglobin A1c (%) | 5.4 ± 0.6 (n = 75) |
Fasting plasma glucose (mg/dl) | 97.0 ± 22.1 |
Fasting insulin (μU/ml) | 9.8 ± 5.7 (n = 40) |
HOMA-IR | 2.2 ± 1.5 (n = 40) |
Leptin (ng/ml) | 7.6 ± 5.1 |
Adiponectin (ng/ml) | 9.0 ± 6.2 |
Resistin (ng/ml) | 8.5 ± 4.6 |
AIM (μg/ml) | 1.39 ± 0.86 |
Hyaluronic acid (ng/ml) | 95.9 ± 114.0 (n = 75) |
α-fetoprotein (ng/ml) | 7.1 ± 11.2 |
Histologic characteristics | Â |
 Activity [A0-1/2-3] | 32/45 |
 Fibrosis [F0-1/2-3] | 36/41 |
 Steatosis [<5%/≥5%] | 59/18 |